Journal Club: Characteristics and feeding intolerance in critically ill adult patients receiving peptide-based enteral nutrition
Recorded by Dietitian Connection on December 3, 2025

CDR Required Learner Assessment and Feedback Survey

Question Title

* 1. What is a cross-sectional study?

Describes a population or situation

Compares individuals with and without a given condition to establish risk factors for disease or condition

Observation with a specific population sample at one point intime (not longitudinal or on-going)

Observation of a group in a longitudinal time – prospective or retrospective

Question Title

* 2. Nutrition support strategies for critically ill patients include nutrition protocols that incorporate

Specialized formulas including 100% whey peptide-based formulas

Other peptide-based formulas

Standard intact protein formulas

All of the above

Question Title

* 3. What is the null hypothesis for this study?

There will be no difference in EFI between patients on 100% whey-based EN formulas vs other peptide-based formulas or standard intake-protein formulas.

There will be a difference in weight loss between patients on 100% whey-based EN formulas vs other peptide-based formulas or standard intact-protein formulas.

Question Title

* 4. Your hospital has IPB, OPB and OPB high protein products on formulary, for which group could you “make a case” for a WPB VHP formula based on the current study?

All ICU patients

ICU patients with GI intolerance

ICU patients with Hyperglycemia

None, this wasn’t a randomized controlled trial

Question Title

* 1. What is a cross-sectional study?

Question Title

* 2. Nutrition support strategies for critically ill patients include nutrition protocols that incorporate

Question Title

* 3. What is the null hypothesis for this study?

Question Title

* 4. Your hospital has IPB, OPB and OPB high protein products on formulary, for which group could you “make a case” for a WPB VHP formula based on the current study?​

* 4. Your hospital has IPB, OPB and OPB high protein products on formulary, for which group could you “make a case” for a WPB VHP formula based on the current study?